Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-B-FAHF-2 with Omalizumab and Multi-OIT in Food Allergy
NCT02879006Phase 2Unknown
- Start
- Aug 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of E-B-FAHF-2 in food allergy. Status: unknown.
02
Drugs
E-B-FAHF-2
03
Conditions
food allergy
Beyond the preview
Go deeper on NCT02879006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02879006.